Touchlight

Touchlight is a contract development and manufacturing organisation producing synthetic DNA for genetic medicine applications using a cell-free enzymatic process.

Its linear, covalently closed DNA constructs are free from bacterial sequences and antibiotic resistance genes, offering regulatory and safety advantages over conventional plasmid DNA produced by bacterial fermentation.

The company holds the world's first cell-free DNA GMP licence and an FDA Drug Master File, with multiple client products currently in clinical trials.